{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:31:56Z","timestamp":1789565516426,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971860"],"award-info":[{"award-number":["81971860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772110"],"award-info":[{"award-number":["81772110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670235"],"award-info":[{"award-number":["81670235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.phrs.2020.105409","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T01:48:27Z","timestamp":1610934507000},"page":"105409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications"],"prefix":"10.1016","volume":"167","author":[{"given":"Le","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaocai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinchuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.phrs.2020.105409_bib0010","first-page":"417","article-title":"Mechanisms and treatment of organ failure in sepsis, Nature reviews","volume":"14","author":"Lelubre","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.phrs.2020.105409_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0020","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/CCM.0b013e31820eda29","article-title":"Is worsening multiple organ failure the cause of death in patients with severe sepsis?","volume":"39","author":"Vincent","year":"2011","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.105409_bib0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"Sepsis campaign bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105409_bib0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.2017.0131","article-title":"Management of sepsis and septic shock","volume":"317","author":"Howell","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728220903460332","article-title":"Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?","volume":"14","author":"Salgado","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/cc8887","article-title":"Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis","volume":"14","author":"Doerschug","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.phrs.2020.105409_bib0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2020.105409_bib0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2020.105409_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0065","doi-asserted-by":"crossref","DOI":"10.1042\/CS20120089","article-title":"The intracrine renin-angiotensin system","volume":"123","author":"Kumar","year":"2012","journal-title":"Clin. Sci. (London, England: 1979)"},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit. Care Clin."},{"issue":"17","key":"10.1016\/j.phrs.2020.105409_bib0075","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1177\/1535370216660211","article-title":"New agents modulating the renin-angiotensin-aldosterone system-will there be a new therapeutic option?","volume":"241","author":"Gromotowicz-Poplawska","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"7","key":"10.1016\/j.phrs.2020.105409_bib0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2020.105409_bib0085","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3109\/10641968709158998","article-title":"Renin-angiotensin system in sepsis","volume":"9","author":"Hilgenfeldt","year":"1987","journal-title":"Clin. Exper. Hypertension. Part A, Theory Pract."},{"issue":"12","key":"10.1016\/j.phrs.2020.105409_bib0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-018-0900-0","article-title":"Inflammation as a regulator of the renin-angiotensin system and blood pressure","volume":"20","author":"Satou","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2020.105409_bib0095","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00424-018-2183-3","article-title":"The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice","volume":"470","author":"Meurer","year":"2018","journal-title":"Pflugers Arch."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0100","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1213\/01.ane.0000281144.06703.0d","article-title":"Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema","volume":"105","author":"Votta-Velis","year":"2007","journal-title":"Anesth. Analg."},{"issue":"7047","key":"10.1016\/j.phrs.2020.105409_bib0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0110","first-page":"287","article-title":"LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells, in vitro cellular & developmental biology","volume":"50","author":"Hermanns","year":"2014","journal-title":"Animal"},{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0115","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00134-009-1545-x","article-title":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","volume":"35","author":"Hagiwara","year":"2009","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.phrs.2020.105409_bib0120","doi-asserted-by":"crossref","first-page":"27911","DOI":"10.1038\/srep27911","article-title":"Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-\u03baB signaling pathways","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/CCM.0b013e3181958d91","article-title":"Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models","volume":"37","author":"Hagiwara","year":"2009","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of angiotensin II type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2020.105409_bib0140","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK\/NF-\u03baB pathways","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2020.105409_bib0145","doi-asserted-by":"crossref","first-page":"108971","DOI":"10.1016\/j.biopha.2019.108971","article-title":"Sini decoction ameliorates sepsis-induced acute lung injury via regulating ACE2-Ang (1-7)-Mas axis and inhibiting the MAPK signaling pathway","volume":"115","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2009.10.006","article-title":"Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock","volume":"49","author":"Schmidt","year":"2010","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0155","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc12809","article-title":"The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension","volume":"17","author":"Mederle","year":"2013","journal-title":"Crit. Care (London, England)"},{"issue":"9","key":"10.1016\/j.phrs.2020.105409_bib0160","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","article-title":"Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis","volume":"29","author":"Bucher","year":"2001","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00418-014-1275-1","article-title":"Expression of the Mas receptor is upregulated in skeletal muscle wasting","volume":"143","author":"Morales","year":"2015","journal-title":"Histochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105409_bib0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/CS20140840","article-title":"Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism","volume":"129","author":"Morales","year":"2015","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2020.105409_bib0175","doi-asserted-by":"crossref","first-page":"F496","DOI":"10.1152\/ajprenal.00121.2014","article-title":"Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia","volume":"311","author":"Rosa","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jss.2013.08.004","article-title":"(Pro)renin receptor blocker improves survival of rats with sepsis","volume":"186","author":"Hirano","year":"2014","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.119.13197","article-title":"Effect of renin-angiotensin-Aldosterone system inhibitors on short-term mortality after Sepsis: a population-based cohort study","volume":"75","author":"Hsu","year":"2020","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0190","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2020.105409_bib0195","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit. Care Med."},{"issue":"17","key":"10.1016\/j.phrs.2020.105409_bib0200","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2020.105409_bib0205","first-page":"CD003709","article-title":"Vasopressors for hypotensive shock","volume":"2","author":"Gamper","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0210","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","article-title":"Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis","volume":"42","author":"Correa","year":"2014","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.105409_bib0215","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0230","doi-asserted-by":"crossref","DOI":"10.1097\/01.ccm.0000528062.45598.be","article-title":"Effect of disease severity on survival in patients receiving angiotensin II for vasodilatory shock","volume":"46","author":"Szerlip","year":"2018","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13613-019-0536-5","article-title":"Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial","volume":"9","author":"Ham","year":"2019","journal-title":"Ann. Intensive Care"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40256-018-0297-9","article-title":"FDA approval of angiotensin II for the treatment of hypotension in adults with distributive shock","volume":"19","author":"Senatore","year":"2019","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.phrs.2020.105409_bib0245","doi-asserted-by":"crossref","first-page":"k4891","DOI":"10.1136\/bmj.k4891","article-title":"Sepsis associated acute kidney injury","volume":"364","author":"Poston","year":"2019","journal-title":"BMJ (Clin. Res. ed.)"},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0250","doi-asserted-by":"crossref","first-page":"R629","DOI":"10.1152\/ajpregu.2000.279.2.R629","article-title":"Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole","volume":"279","author":"Denton","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Compar. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0255","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMra064398","article-title":"Normotensive ischemic acute renal failure","volume":"357","author":"Abuelo","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.105409_bib0260","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit. Care (London, England)"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0265","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/CCM.0000000000002797","article-title":"Urinary oxygenation as a surrogate measure of medullary oxygenation during angiotensin II therapy in septic acute kidney injury","volume":"46","author":"Lankadeva","year":"2018","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.medin.2016.07.010","article-title":"Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury","volume":"41","author":"Suberviola","year":"2017","journal-title":"Med. Intensiva"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0275","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0280","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","article-title":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets","volume":"38","author":"Treml","year":"2010","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","article-title":"Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation","volume":"43","author":"Li","year":"2015","journal-title":"Shock (Augusta, Ga.)"},{"issue":"3","key":"10.1016\/j.phrs.2020.105409_bib0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10787-018-0535-4","article-title":"Immunomodulatory properties of captopril, an ACE inhibitor, on LPS-induced lung inflammation and fibrosis as well as oxidative stress","volume":"27","author":"Boskabadi","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phrs.2020.105409_bib0295","doi-asserted-by":"crossref","first-page":"117051","DOI":"10.1016\/j.lfs.2019.117051","article-title":"The protective effects of angiotensin-converting enzyme inhibitor against cecal ligation and puncture-induced sepsis via oxidative stress and inflammation","volume":"241","author":"Kostakoglu","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0300","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SHK.0b013e318189017a","article-title":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases","volume":"31","author":"Shen","year":"2009","journal-title":"Shock (Augusta, Ga.)"},{"issue":"10","key":"10.1016\/j.phrs.2020.105409_bib0305","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00210-014-1014-0","article-title":"What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury","volume":"387","author":"Akpinar","year":"2014","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart: current understanding of molecular mechanisms and clinical implications","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"issue":"39","key":"10.1016\/j.phrs.2020.105409_bib0315","doi-asserted-by":"crossref","first-page":"e5031","DOI":"10.1097\/MD.0000000000005031","article-title":"Prevalence and risk factors of sepsis-induced cardiomyopathy: a retrospective cohort study","volume":"95","author":"Sato","year":"2016","journal-title":"Medicine"},{"issue":"14","key":"10.1016\/j.phrs.2020.105409_bib0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF01716561","article-title":"The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock","volume":"60","author":"Lefer","year":"1982","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.phrs.2020.105409_bib0325","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fphar.2020.00210","article-title":"Current status of septic cardiomyopathy: basic science and clinical progress","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0330","first-page":"116","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease, Nature reviews","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Cardiology"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcb.27445","article-title":"AT1R knockdown confers cardioprotection against sepsis-induced myocardial injury by inhibiting the MAPK signaling pathway in rats","volume":"121","author":"Zhang","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00059-017-4537-6","article-title":"Cardioprotective effects of irbesartan in polymicrobial sepsis: the role of the p38MAPK\/NF-\u03baB signaling pathway","volume":"43","author":"Yousif","year":"2018","journal-title":"Herz"},{"key":"10.1016\/j.phrs.2020.105409_bib0345","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lfs.2018.04.010","article-title":"Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways","volume":"206","author":"Li","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0350","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0355","first-page":"5492","article-title":"Angiotensin\u2011(1\u20117) prevents lipopolysaccharide\u2011induced hepatocellular inflammatory response by inhibiting the p38MAPK\/AP\u20111 signaling pathway","volume":"17","author":"Xiao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2020.105409_bib0360","series-title":"Semin Cardiothorac Vasc Anesth","article-title":"Angiotensin II in decompensated cirrhosis complicated by septic shock","author":"Coleman","year":"2019"},{"issue":"6","key":"10.1016\/j.phrs.2020.105409_bib0365","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","article-title":"Long-term cerebral consequences of sepsis","volume":"13","author":"Widmann","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0370","first-page":"61","article-title":"Cognitive decline after sepsis, the lancet","volume":"3","author":"Annane","year":"2015","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.phrs.2020.105409_bib0375","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.imbio.2015.07.013","article-title":"Mas receptor deficiency exacerbates lipopolysaccharide-induced cerebral and systemic inflammation in mice","volume":"220","author":"Oliveira-Lima","year":"2015","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0380","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20140215","article-title":"Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism","volume":"128","author":"Cisternas","year":"2015","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0385","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00418-014-1275-1","article-title":"Expression of the Mas receptor is upregulated in skeletal muscle wasting","volume":"143","author":"Morales","year":"2014","journal-title":"Histochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0390","first-page":"138","article-title":"Medical progress: the pathophysiology and treatment of sepsis, New Engl","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"J. Med."},{"key":"10.1016\/j.phrs.2020.105409_bib0395","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2017.02.040","article-title":"Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: novel therapeutic implications and challenges","volume":"177","author":"Hattori","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"21","key":"10.1016\/j.phrs.2020.105409_bib0400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of sepsis and potential therapeutic targets","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2020.105409_bib0405","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2020.105409_bib0410","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.bbadis.2017.01.013","article-title":"Microbial recognition and danger signals in sepsis and trauma","volume":"1863","author":"Raymond","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0415","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105409_bib0420","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0425","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.phrs.2020.105409_bib0430","doi-asserted-by":"crossref","first-page":"104350","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"issue":"7798","key":"10.1016\/j.phrs.2020.105409_bib0435","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"10224","key":"10.1016\/j.phrs.2020.105409_bib0440","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0445","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/cc12896","article-title":"Characteristics and outcomes of culture-negative versus culture-positive severe sepsis","volume":"17","author":"Phua","year":"2013","journal-title":"Crit. Care (London, England)"},{"issue":"10","key":"10.1016\/j.phrs.2020.105409_bib0450","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s10096-017-2990-z","article-title":"Respiratory viral infections are underdiagnosed in patients with suspected sepsis","volume":"36","author":"Ljungstr\u00f6m","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"18","key":"10.1016\/j.phrs.2020.105409_bib0455","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105409_bib0460","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030623","article-title":"Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review","volume":"9","author":"Pang","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.013","article-title":"SnapShot: COVID-19","volume":"181","author":"Oberfeld","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2020.105409_bib0470","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for Coronavirus disease 2019 (COVID-19): a review","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2020.105409_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.phrs.2020.105409_bib0480","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105409_bib0485","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"10223","key":"10.1016\/j.phrs.2020.105409_bib0490","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.phrs.2020.105409_bib0495","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.phrs.2020.105409_bib0500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0505","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci. (London, England\u202f: 1979)"},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0510","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105409_bib0515","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.phrs.2020.105409_bib0520","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.105409_bib0525","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1096\/fj.202000782","article-title":"Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: a double-edged sword?","volume":"34","author":"Yan","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2020.105409_bib0530","doi-asserted-by":"crossref","DOI":"10.7861\/clinmed.2020-0146","article-title":"The renin-angiotensin system - a therapeutic target in COVID-19?","author":"Sturrock","year":"2020","journal-title":"Clin. Med. (London, England)"},{"key":"10.1016\/j.phrs.2020.105409_bib0535","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0540","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"17","key":"10.1016\/j.phrs.2020.105409_bib0545","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-Aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2020.105409_bib0550","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2020.105409_bib0555","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is No evidence to abandon renin-angiotensin system blockers","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2020.105409_bib0560","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients","volume":"9","author":"Rossi","year":"2020","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.phrs.2020.105409_bib0565","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13054-020-02928-0","article-title":"Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series","volume":"24","author":"Zangrillo","year":"2020","journal-title":"Crit. Care (London, England)"},{"key":"10.1016\/j.phrs.2020.105409_bib0570","article-title":"Unexpected BP sensitivity to angiotensin II in a patient with Coronavirus disease 2019, ARDS, and septic shock","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.phrs.2020.105409_bib0575","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.0000251700.00994.0d","article-title":"A novel signal transduction cascade involving direct physical interaction of the renin\/prorenin receptor with the transcription factor promyelocytic zinc finger protein","volume":"99","author":"Schefe","year":"2006","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2020.105409_bib0580","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J. Clin. Invest."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820317175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820317175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:42:16Z","timestamp":1778794936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820317175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":116,"alternative-id":["S1043661820317175"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105409","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105409"}}